Atlas Trials

A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

Clinical trial NCT06595238 · COMPLETED

Trial details

NCT number
NCT06595238
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity or Overweight
Start date
2024-10-01
Primary completion
2025-12-03
Enrollment
262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.